Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Treatment trajectories and outcomes in inflammatory bowel disease: a tertiary single-centre experience
Publication Year: 2024 Source: Therap Adv Gastroenterol PMID: 39381754 DOI: 10.1177/17562848241284051
BACKGROUND: There is an increasing diversification in the treatment landscape for inflammatory bowel diseases (IBD) leading to therapeutic challenges that can only incompletely be covered by prospective randomized double-blind trials. Real-world observations are therefore an important tool to provide insights into therapeutic strategies. OBJECTIVES: To describe the real-world treatment algorithms …
Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patients
Publication Year: 2024 Source: Pharmacogenomics PMID: 39382000
No Abstract
Comment on: Coinciding Crohn's disease and polyarteritis nodosa: A sign of medically refractory disease?
Publication Year: 2024 Source: Int J Rheum Dis PMID: 39382239
No Abstract
Incidence of intestinal & extra-intestinal cancers among individuals with Crohn's disease in northern India
Publication Year: 2024 Source: Indian J Med Res PMID: 39382506
No Abstract
Therapeutic drug monitoring in inflammatory bowel disease: recent developments
Publication Year: 2024 Source: Expert Rev Gastroenterol Hepatol PMID: 39382556 DOI: 10.1080/17474124.2024.2409300
INTRODUCTION: Therapeutic Drug Monitoring (TDM) has an important role in the management of inflammatory bowel disease (IBD) patients on infliximab (IFX) or adalimumab and is recommended in IBD patients presenting a loss of response under anti TNF agent. But, TDM was not recommended for others biotherapies. AREAS COVERED: Analyzing all …
Successful treatment of Crohn's disease-related peripheral spondyloarthritis with upadacitinib: two case reports and case-based review
Publication Year: 2024 Source: Rheumatol Int PMID: 39382686 DOI: 10.1007/s00296-024-05735-w
Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease (CD), not only causes significant intestinal inflammation but also leads to extra-intestinal manifestations such as spondyloarthritis (SpA). Although the efficacy of tumor necrosis factor (TNF) inhibitors has been reported for IBD-related SpA, some cases still encounter treatment failure, highlighting the …
Antibiotic Exposure and Risk of New-Onset Ulcerative Colitis: a Systematic Review and Meta-Analysis
Publication Year: 2024 Source: Clin Lab PMID: 39382910
No Abstract
Pharmacological treatment of postoperative recurrence of Crohn's disease: Protocol for systematic review and network meta-analysis
Publication Year: 2024 Source: PLoS One PMID: 39383157
No Abstract
Identification of novel indolinone derivatives as CTSC inhibitors to treat inflammatory bowel disease by modulating inflammatory factors
Publication Year: 2024 Source: Eur J Med Chem PMID: 39383651 DOI: 10.1016/j.ejmech.2024.116914
Novel inflammatory bowel disease (IBD) therapeutic drugs, mainly biologics that neutralize pro-inflammatory factors and janus kinase inhibitors that inhibit cytokine-mediated signal transduction, face problems including low efficacy rates, limited therapeutic benefits, and infection risks. It is an important task to find proteins that broadly regulate a variety of cytokines and …
Environmentally relevant level of PFDA exacerbates intestinal inflammation by activating the cGAS/STING/NF-κB signaling pathway
Publication Year: 2024 Source: Sci Total Environ PMID: 39383958 DOI: 10.1016/j.scitotenv.2024.176786
As a constituent of the Per- and Polyfluoroalkyl Substances (PFAS) family, perfluorodecanoic acid (PFDA) is ubiquitous in the environment and enters the human body through environmental exposure, the food chain, and other pathways, resulting in various toxic effects. Previous population-based studies have suggested a correlation between PFDA exposure and inflammation. …
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide